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Abstract 
BACKGROUND: Angioedema (AE) is acute oedema of the skin and mucous surfaces, involving the respiratory 
and gastrointestinal tracts. AE could be a life-threatening medical condition. Regardless of its growing clinical 
importance, many aspects of its aetiology and pathogenesis remain poorly understood. Its incidence, 
demographic characteristics, diagnosis and therapy, need further investigation. 
AIM: This study reports our experience with angioedema concerning its social and demographic characteristics, 
aetiology, clinical features, diagnosis and treatment outcomes. Study design: Eighty-eight patients with AE were 
enrolled. The study is a retrospective analysis of patients treated in our Clinics. 
METHODS: All participants were asked on a voluntary basis to fill out a specially designed questionnaire on the 
day of their discharge. Other important data sources included: patients’ history and notes during the hospital stay, 
information from previous admissions, etc. Parametric and non-parametric statistical methods were used for data 
processing. Data analysis was performed using SPSS (SPSS Inc., IBM SPSS Statistica) version 20.0 
RESULTS: Based on our results, AE affects more frequently patients over 50 years of age, regardless of their 
sex. Urban residents prevail, among them - more commonly working women. Non-steroidal anti-inflammatory 
drugs (NSAIDs), hormones and antibiotics were among the most common triggers – in 8%, 4.5% and 11.4% of 
the cases respectively. In 9.09% of the patients, food-induced AE was seen, the most common foods reported, 
were – nuts, eggs and egg products. The common sites of involvement were periorbital area and lips. In only 
9.1% of the patients, oedema progressed to spread to the upper respiratory tract. Cardiac conditions were the 
most frequent underlying disorders – 33%, of the patients, auto-immune thyroiditis was the second most common-
14.8%, followed by musculo- skeletal disorders (10.2%) and diabetes (4.5%) Family history of allergy was seen in 
8.4% of the patients, the most frequent allergic disorder, reported, was asthma. In patients with HAE, family 
history was present in 2.9% of the patients. 
CONCLUSIONS: All patients received therapy with steroids and antihistamines, resulting in resolution of 
symptoms and no invasive procedures were necessary. Based on our results, the diagnosis of AE is often difficult 
and delayed and requires specialist evaluation. If recognised on time and adequately treated, the outcomes are 
favourable. 
 
 
 
 
 
 
 
Introduction 
 
Angioedema (AE) usually presents with 
oedema of the deep layers of the skin, located 
predominantly on the eyelids, lips, tongue, pharynx 
and larynx. However, it may also affect other parts of 
the body, including the extremities. Regardless of its 
growing clinical importance, many aspects of its 
aetiology and pathogenesis remain poorly understood. 
It is the objective of this study to present a detailed 
picture of the incidence, aetiology, triggering factors 
and pathology of AE. An attempt is made to describe 
the complexity and the many different aspects of the 
clinical presentation, the sociodemographic and 
clinical characteristics, the causal factors and the 
current diagnostic criteria as well as the therapeutic 
approaches. The analysis is made, based on our 
more than 5-years experience with the condition. A 
comparison is drawn between our diagnostic and 
therapeutic approach to these patients against the 
established criteria, based on data in the available 
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literature. 
Henrich Quinke [1] first described the clinical 
picture of AE in 1882. Though it is known that there 
had been some earlier descriptions – by Marcelo 
Donatti in 1586 [2] and by John Milton [3] in 1876. In 
1888, W. Osler [4] reported the first cases of the 
hereditary form of the disease; he coined the term 
"hereditary angioneurotic oedema. In 1961, Lepou et 
al. discovered the C1 esterase inhibitor (C1-INH) and 
demonstrated that it increases vascular permeability 
in guinea pigs. In 1962, Landerman [5] suggested that 
the reduced levels of kallikrein could trigger the 
formation of oedema. Donaldson and Evans [6], [7] 
were the first to describe family members of AE 
patients with reduced C1-INH levels and respective 
elevation of C1 esterase concentration. In our country, 
the first case of AE was reported at the first National 
Allergy Conference in 1976 [8]. Throughout 30 years, 
at the National Allergy Clinical Center, a database 
was developed, including approximately 39 affected 
families – 120 patients [8]. In the last decades, new 
forms of acquired AE have been described, and 
significant progress has been made in clarifying the 
aetiology, pathogenetic mechanisms, and the genetics 
of the disease. Serious advances have been achieved 
in the management of AE. Due to accumulated 
knowledge, current diagnosis of AE requires the 
definition of its type. Attempts to classify AE types 
have been made after it was first described. At 
present, there is an international consensus that AE 
could be hereditary (HAE) or acquired (AAE). 
However, the international task group [9] on AE, 
analysing and summarising the data, introduced a 
new classification of AE in 2014. Based on this 
classification if AAE responds to antihistamines, it is 
termed histaminergic AE – (IH-AAE). In this case, 
exposure to allergens should be sought. Another form 
is the idiopathic non- histaminergic AAE (InH-AAE). It 
responds well to prophylaxis with tranexamic acid. It 
was first described by Cicardi et al., [10]. There is an 
AAE form related to the use of angiotensin-converting 
enzyme inhibitors (ACEI-AAE). This enzyme plays a 
crucial role in the metabolism of bradykinin. It is seen 
in < 0.5% of hypertensive patients and is more 
common in Africans [11]. Acquired AE with C1INH 
(C1-INH-AAE) deficiency has also been defined. In 
this form, there is no family history or established 
gene mutations. It seems related to depletion of 
C1INH and is seen mainly in lymphoproliferative 
disorders. In hereditary AE-two phenotypes are 
described – type I with quantitative reduction of C1-
INH (C1-INH-HAE type I), and type II – with normal 
C1-INH level, but it is non – functional-(C1-INH-HAE 
type II) [12]. Another form of HAE is characterized by 
normal C1INH level and accompanying mutation of 
factor XII (FXII-HAE). The likely etiology in this case is 
a missense mutation of the factor XII gene [13]. 
However, there are patients, non – carriers of this 
mutation who exhibit AE. This form is of unknown 
aetiology and is termed U-HAE [14]. AE, as seen from 
the classification as mentioned above, has many 
subtypes. The key to its understanding is that fact, 
that histamine and bradykinin are the most recognized 
vaso-active mediators known to be critical in the 
pathological process; most cases of AE are primarily 
mediated by 1 of these 2 mediators. The final result is 
increased capillary permeability, leading to plasma 
extravasation and accumulation in the deeper layers 
of the skin and submucosa Figure 1.   
 
Figure 1: Classification of angioedema 
 
 
Material and Methods 
 
The study was conducted at a Clinic of Allergy 
and Occupational Diseases. It encompassed all 
patients with AE, admitted and treated at the Clinics 
from January 1, 2010, to December 31, 2014.  
Analyzed variables were categorized as 1. 
factorial – age, sex, place and district of residence, 
social status, occupation; 2. resultative – diagnosis at 
admission and discharge, disease outcome, previous 
admissions, etiology, other underlying medical 
conditions, family history, location of the edema and 
its dynamics, diagnostic criteria, laboratory tests, 
treatment and therapeutic outcomes.  
Two basic methods of medical sociology were 
applied during data collection: medical interview and 
analysis of documents.  
The study medical questionnaire was 
developed before the conduction of the study. The 
first variant was initially tested with 20 patients. This 
allowed further detailization and clarification of the 
content of questions. Some questions were added, 
and others were deleted from the questionnaire.  
The questionnaire included 56 open-ended, 
semi-open-ended and closed questions. They were 
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grouped into 5 categories as follows:  
- social and demographic 
characteristics of the patients; 
- hospital treatment; 
- aetiology; 
- clinical features and diagnosis; 
- laboratory diagnosis. 
Document analysis was performed based on 
patients’ hospital papers. Data were entered in a 
specialised database.  
All participants were asked on a voluntary 
basis to fill out the questionnaire on the day of their 
discharge. Other important data sources included: 
patients history and notes during the hospital stay, 
information from previous admissions, etc.  
Primary information was translated, coded 
and entered into a specialised data base. At a second 
stage, data were grouped, aggregating factorial and 
resultative variables to allow summarisation and 
analysis, thus meeting the study objective. The 
following statistical methods were used:  
- Descriptive statistical methods: 
extensive variable analysis and graphic analysis 
- Analysis of variance – for quantitative 
data processing. To test the normality of the 
distribution, Kolmogorov-Smirnov λ criterion was 
applied. U criterion was used to compare the two 
sample means. Statistical significance and evidence 
in support of the null hypothesis were assumed at p = 
0.05.  
- Parametrical tests were applied for 
quantitative variables. Depending on the parameters 
of interest both the classic and Fisher’s exact tests 
were used. To calculate percentages, Van der 
Vaerden test was applied.  
- Correlation analysis was used to test 
the relationships between factorial and resultative 
variables. Regression analysis was applied to assess 
quantitative relationships.  
- Non- parametric tests – non-
parametrical tests were used to test hypothesis not 
meeting the criteria for normal distribution. Used tests 
included: Pearson’s squared test, Kolmogorov- 
Smirnov test, Wilcoxon- Mann – Whitney and Kruskal- 
Wallis tests.  
- Dispersion analysis (Tukey’s) tests 
were applied to allow comparison among multiple 
pairs of means.  
- The method of the least squares was 
used to equalise dynamic data lines (for the period 
January 1, 2010, and February 1, 2017) and find the 
best fit for the data sets.  
- The graphic analysis allowed 
visualisation of the observed relationships and 
processes.  
Data procession was performed using SPSS 
(SPSS Inc., IBM SPSS Statistica) version 20.0 and 
Microsoft Office 2010 platform.  
 
 
Results 
 
In the studied period, 88 patients with 
suspected AE on admission were treated at the 
Clinics of Allergy and Occupational Disorders. 
Regarding their socio-demographic characteristics, it 
was found out that: most patients with AE were over 
50 years of age, the condition affected equally males 
and females, the sex differences being statistically 
insignificant in all age groups. Results are presented 
in Table 1.  
Table 1: Distribution of the studied contingent according to 
age group and sex in AE 
Age group 
Males Females Total 
Number % Sp Number % Sp Number % 
Up to 30 years of 
age 
7 20.00 6.40 4 7.55 4.15 11 12.50 
Between 30-40 
years of age . 
9 25.71 7.39 9 16.98 5.16 18 20.45 
Between 40-50 
years of age. 
3 8.57 4.74 11 20.75 5.58 14 15.91 
Over 50 years of 
age 
16 45.71 8.42 29 54.72 6.84 45 51.14 
Total 35 100.00 - 53 100.00 - 88 100.00 
 
Regarding the place of residence, most 
patients were urban residents, however, among urban 
residents; females were predominant (61.7%). 
Regarding socio-economic status, working females 
were prevailing (53.6%), the percentage of students 
was least-0.9%. The occupational characteristics of 
the study population were also addressed as 
occupational exposure could play a role as a trigger in 
AE. Of the study contingent, 9 patients were medical 
professionals. Of them, women, assistant nurses were 
predominant (30.5%), most of the men worked in the 
hospital administration (70.8%). Finally, some 
seasonal distribution of the cases was established – 
the number of admitted patients with AE peaked in 
early spring and autumn.  
Among cases with HAE, emergency hospital 
admissions predominate, whereas other AE cases, 
attended as either emergency patients or as planned 
admissions. (46% and 54% respectively) This fact 
illustrated the need for detailed diagnostic work up, 
laboratory tests and planned long term treatment 
necessary in AE as well as the need to manage acute 
attacks of AE. The median duration of the hospital 
stay was 3 days.  
Our study demonstrates that 34.1% of our 
patients have no history of taking medication before 
the onset of AE, however, drug-induced AE could be 
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suspected in 42.05% of the cases. Based on our data 
the most common therapeutic agents implicated in the 
aetiology of AE were: NSAID, including aspirin (8% 
and 3.9%) hormones (estrogen – 4.5) and antibiotics 
– 11.4% Table 2.  
Table 2: Etiology of drug-induced AE  
Medication 
Based on the patient's history 
Total 
No Yes 
Number % Sp Number % Sp Number % 
NSAID 81 92.0 2.89 7 8.0 2.89 88 100 
Acetyl-salicilic acid and derivatives 74 84.1 2.51 14 15.9 3.90 88 100 
Analgesics, anti-pyretics, anaestetics 81 92.0 2.89 7 8.0 2.89 88 100 
Anti-platelet agents 86 97.7 1.60 2 2.3 1.60 88 100 
Antibiotics 78 88.6 3.39 10 11.4 3.39 88 100 
Radio-contract dyes 88 100 - 0 0 0.0 88 100 
Psychoactive agents 86 97.7 1.60 2 2.3 1.60 88 100 
Beta-blocking agents 87 98.9 1.11 1 1.1 1.11 88 100 
Herbs 87 98.9 1.11 1 1.1 1.11 88 100 
Cytostatics 87 98.9 1.11 1 1.1 1.11 88 100 
Hormones 84 95.5 2.21 4 4.5 2.21 88 100 
Transfusion of plasma, plasma 
substitutes and colloid solutions 
88 100 - 0 0 0 88 100 
Local therapeutic agents 82 93.2 2.68 6 6.8 2.68 88 100 
Homeopathic agents 88 100 - 0 0 0 88 100 
Vitamins 88 100 - 0 0 0 88 100 
Latex products 88 100 - 0 0 0 88 100 
Synthetic polymers and plastics 84 95.5 2.21 4 4.5 2.21 88 100 
Other 62 70.5 4.86 26 29.5 4.86 88 100 
 
It is worth noting that in some cases, the 
triggering medication could not be identified.  
Based on the results from our study, food-
induced AE could be suspected in 9.09% of the 
cases. Nuts, eggs and egg products, as well as sea 
foods, were most frequently involved. Insect bites, 
radio contract dyes and physical agents were not 
commonly implicated in the aetiology of AE, based on 
the results of our study. Interestingly, stress and 
sustained trauma as triggers of AE, in our research 
were identified in 30% of the cases. However, 
repeated trauma did not result in an increased 
frequency of edemas. The relationship of AE with 
other underlying medical conditions, especially allergic 
and auto-immune have been addressed in other 
research works. Our study demonstrated that in AE 
patients, most frequently cardiac conditions were 
identified (33%). Auto-immune thyroiditis was the 
second most common-14.8%, followed by musculo- 
skeletal disorders (10.2%) and diabetes (4.5%) Family 
history of allergy was seen in 8.4% of the patients, the 
most frequent allergic disorder, reported, was asthma. 
In patients with HAE, family history was present in 2.9 
% of the patients.  
According to the findings in our research, half 
of the patients were diagnosed at the specialised 
Clinics of Allergic Disorders, in 20% of the cases, the 
primary care physician established the diagnosis, the 
remaining-were diagnosed at the Emergency Centers-
15.9%. Most patients were diagnosed after having 
recurrent attacks-43.2%, only 5% were diagnosed 
after the first attack. The diagnosis of AE was based 
on the internationally established criteria – history, 
clinical symptoms and allergic status; laboratory tests 
were performed in 54% of the patients. Clinically, AE 
most frequently affected the face, including the lips 
and eyelids (43.2%). The oedema was located on the 
lips only in ¼ of the patients, the involvement of the 
eyelids was even less frequent-13.6%. Facial 
oedema, progressing to involve the upper respiratory 
tract was seen only in 9.1%. It is worth noting that 
prodromal symptoms were seen in the majority of 
cases – 84.1% of our cases. Prodromal symptoms are 
presented in Table 3.  
Table 3: Signs and symptoms associated with AE 
Symptoms  Based on the patient's history Total 
No Yes 
Number % Sp Number % Sp Number % 
Itching  29 33.0 5.01 59 67.0 5.01 88 100 
Redness  66 75.0 4.62 22 25.0 4.62 88 100 
Pain  86 97.7 1.59 2 2.3 1.59 88 100 
Rash  42 47.7 5.32 46 52.3 5.32 88 100 
Breathlessness  81 92.0 2.88 7 8.0 2.88 88 100 
Hoarseness 78 88.6 3.38 10 11.4 3.38 88 100 
Nasal congestion  85 96.6 1.93 3 3.4 1.93 88 100 
Running nose  85 96.6 1.93 3 3.4 1.93 88 100 
Wheezing 86 97.7 1.59 2 2.3 1.59 88 100 
Other  69 78.4 4.39 19 21.6 4.39 88 100 
 
In most cases, AE is accompanied by other 
symptoms as follows: 30.7 % of the patients present 
with at least two accompanying symptoms, 23.9%- 
report three symptoms and 20.5% had only one 
accompanying symptom. Another important issue, 
regarding AE is the evolution and course of oedema 
as it influences the choice of treatment approaches. 
Based on our research, in 71.6% of the cases, the 
oedema is self-limiting and does not progress to 
involve other body parts; oedema expands in 15.9% 
of the cases; in 12.5% of the patients, its duration was 
more than 24 hours regardless of the administered 
therapy. In 35.2% of the patients, AE is the only 
presentation and is rarely associated with other 
allergic and auto-immune disorders.  
In our study patients, the diagnosis was 
based on the established diagnostic criteria. 
Laboratory tests were performed in 54%. All patients 
received anti-histamines and steroids with a very good 
therapeutic effect. The results are presented in Figure 
2.  
 
 
Figure 2: Treatment outcome in angioedema 
 
All patients in our study received treatment. In 
95.4% of them, it resulted in complete resolution of AE 
after the application of anti-histamines and steroids. In 
73.3% of the patients, favourable therapeutic results 
were seen after the third hour.  
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Laboratory tests were performed in 23.9 % of 
the patients to exclude HAE. Diagnostic laboratory 
tests were: the level of C1esterase inhibitor, the level 
of functional C1INH and the level of C4. In all cases, 
the tests were within the reference levels. Skin allergy 
prick tests were performed in 52 patients, and IgE 
levels were tested in 86 patients. Allergy to pollens 
was noted in 13.6% of the patients, to occupational 
allergens in 8.0%; the remaining 4.5% had 
documented allergy to domestic dust, mites and pets. 
Specific IgE was detected in only one patient.  
 
 
Discussion 
 
Regarding the social and demographic 
characteristics, our research showed that most 
admitted patients were over 50years of age. This fact 
seems related to the finding that medication was the 
most common triggering factor for AE with NSAID 
being predominant. No significant differences based 
on sex were reported unlike other studies (Cohen et 
al.) that found female predominance [15]. However, 
male predominance has also been reported [16], [17]. 
The likely explanation for female predominance is that 
estrogens have been found to exacerbate type III 
HAE. In our study, no sex differences were 
established. However, hormones were the third most 
common triggering factor for AE. A total of 88 patients 
were diagnosed and treated for AE at the Clinics in 
the studied period. Among them, urban residents were 
53.3%, of them working women were predominant. 
More cases were registered in the early spring and 
autumn. It is known from the literature that AE has 
been frequently associated with other allergic and 
autoimmune disorders. Our study provides further 
evidence of this finding – the most common 
accompanying allergic disorder in our patients was 
atopic asthma followed by allergic rhinitis. 
Regarding autoimmune disorders, thyroiditis 
was the second most common co-morbidity. Based on 
the European guidelines, an attempt was made to 
establish the triggers, however, even at discharge the 
aetiology remained unclear in 81.61% of the cases, 
and 13.79 % of the patients had accompanying 
urticaria. The detailed analysis of the triggering factors 
found out that our data was similar to data from the 
literature [18], 42.05% of our patients have a history of 
medication intake-aspirin, (15.9%), other NSAIDs 
(8%), antibiotics (11%), analgesics (8%), 
hormones(4.5%). Rarely there is a history of intake of 
more than 3 different medications. Most patients do 
not associate the AE with food, however, some 
(9.09%) report that certain foods could trigger AE – 
most frequently nuts (5.7%) eggs (4.5%) and fish and 
seafood – 1.1%. This incidence is lower compared to 
literature data [19]. Allergic reaction to food can cause 
IgE mediated hypersensitivity and release of 
mediators from mast cells, followed by accumulation 
of mononuclear cells and neutrophils as part of 
systemic anaphylaxis. However, food allergy can 
occur in cases of direct mast cell mediator release.  
Interestingly, available literature data show a 
relationship between sustained trauma and AE in 54% 
of the cases [20]. In our research, there is a relation 
between trauma and AE but only 30% of the cases. 
Another finding is the association of AE and urticaria 
with other co – morbidities as those with immune 
etiology [20], [21], [22], [23], [24] – a history of atopic 
asthma – in 26 patients (33.3%), allergic rhinitis – in 4 
patients and other allergic conditions in 17 patients 
(eczema atopic dermatitis etc.). In our study, cardiac 
conditions were the most common comorbidities 
(33.3%), followed by auto-immune thyroiditis (14.8%) 
and musculoskeletal disorders (10.2%). In these 
patients, AE seems related to the use of ACEI and 
NSAIDs. The percentage of accompanying auto-
immune disorders is similar to that established by 
other authors [25]. A family history of HAE was 
established in only 0.9% of the cases, which is less 
than the established incidence at the population level. 
There was a family history of allergic disorders (8.4%), 
most commonly asthma – 56%.  
Many authors working in the field of AE, 
report that the diagnosis of the disease usually takes 
time. According to a large study in Spain [25], the 
median time between the first attack and the 
diagnosis of AE is 13 years. In our study, we 
document that in most cases, the diagnosis requires 
evaluation by a specialist. More rarely it is diagnosed 
by the GP and at the Emergency Centers. Regarding 
the clinical features of AE, our findings were similar to 
those reported by other authors [26]- oedema involved 
most frequently the face, the lips and the e eyelids. 
The course was self-limiting in 71. 6% of the cases, 
rarely progressed to involve other body parts – 15% 
and the duration of the symptoms was more than 24 
hours in 12.4%. The international group on AE has 
reported similar findings. Most patients present with 
accompanying symptoms (84.1%). This fact has been 
documented by other authors [26]. Based on the 
results from our study, these symptoms are – itching 
(67%), rash (52.3%) and erythema in the oedema 
zone (25%). Compared to other authors, the 
percentage of redness is slightly higher – 48 %. Most 
patients were admitted and treated at the Clinics after 
they had had more than three attacks (43.2%). This 
finding confirms that the diagnosis of AE is often 
delayed, similarly to other reports in the literature.  
In our study, the diagnosis was based on 
history, clinical features and allergy status. Laboratory 
tests were performed in 54% of the patients. The C1, 
C1INH and C4 levels were tested as well as skin prick 
tests and specific IgE. At least two diagnostic 
procedures were used. All our patients received 
treatment – steroids and anti-histamines, which 
resulted in resolution of symptoms. Specific HAE 
therapy was not applied. No invasive procedures 
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(intubation) were necessary.  
In conclusion, this study presents an overview 
of AE. We attempt to analyse the socio-demographic 
characteristics of AE as well as its most important 
etiological and clinical features. Based on our result, 
this is not an uncommon medical condition. The 
diagnosis is often difficult and delayed and requires 
specialist evaluation. If recognised on time and 
adequately treated, the outcomes are favourable. 
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